Raav with chemically modified capsid
US-2019388557-A1 · Dec 26, 2019 · US
US11020497B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11020497-B2 |
| Application number | US-201816149828-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2018 |
| Priority date | Oct 9, 2012 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A rod-shaped plant virus having an interior surface and an exterior surface, and at least one imaging agent that is linked to the interior and/or exterior surface is described. The rod-shaped viruses can be combined into larger spherical nanoparticles. A rod-shaped plant virus or spherical nanoparticles including an imaging agent can be used in a method of generating an image of a tissue region of a subject such as a tumor or atherosclerotic tissue by administering the virus particle to the subject and generating an image of the tissue region of the subject to which the virus particle has been distributed.
Opening claim text (preview).
What is claimed is: 1. A spherical nanoparticle imaging platform, comprising a spherical arrangement of the coat proteins of one or more rod-shaped plant virus particles linked to an imaging agent on an interior surface of the virus particle, formed by thermal transition of the rod-shaped virus particles, wherein the imaging platform has a longitudinal relaxivity of greater than about 10 mM −1 S −1 per linked imaging agent when measured at 60 mHz at a physiological pH. 2. The spherical nanoparticle imaging platform of claim 1 , wherein the rod-shaped plant virus is a tobacco mosaic virus. 3. The spherical nanoparticle imaging platform of claim 1 , wherein the imaging agent is a chelated lanthanide. 4. The spherical nanoparticle imaging platform of claim 1 , wherein the imaging platform has a longitudinal relaxivity of greater than about 15 mM −1 S −1 per linked imaging agent when measured at 60 mHz at a physiological pH.
Nanotubes, nanorods or nanowires · CPC title
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Uses of virus other than therapeutic or vaccine, e.g. disinfectant · CPC title
not provided for elsewhere, e.g. cells, viruses, ghosts, red blood cells, virus capsides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.